Skip to Content
Learn about Brilinta and how it may lower your risk of having a stroke

Drug interactions between aspirin / dipyridamole and dipyridamole

Results for the following 2 drugs:
aspirin/dipyridamole
dipyridamole

Interactions between your drugs

There were no interactions found in our database between aspirin / dipyridamole and dipyridamole - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

aspirin / dipyridamole

A total of 533 drugs are known to interact with aspirin / dipyridamole.

dipyridamole

A total of 211 drugs are known to interact with dipyridamole.

Drug and food interactions

Moderate

dipyridamole food

Applies to: aspirin / dipyridamole and dipyridamole

Caffeine may interfere with the effects of dipyridamole in dilating the arteries. You should avoid caffeine-containing products for at least 24 hours before an imaging procedure involving dipyridamole given by injection. However, no special precaution is necessary if you are taking dipyridamole orally for maintenance.

Switch to professional interaction data

Therapeutic duplication warnings

Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.

Duplication

Non-nitrate vasodilators

Therapeutic duplication

The recommended maximum number of medicines in the 'non-nitrate vasodilators' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'non-nitrate vasodilators' category:

  • aspirin/dipyridamole
  • dipyridamole

Note: The benefits of taking this combination of medicines may outweigh any risks associated with therapeutic duplication. This information does not take the place of talking to your doctor. Always check with your healthcare provider to determine if any adjustments to your medications are needed.

Duplication

Phosphodiesterase inhibitors

Therapeutic duplication

The recommended maximum number of medicines in the 'phosphodiesterase inhibitors' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'phosphodiesterase inhibitors' category:

  • aspirin/dipyridamole
  • dipyridamole

Note: The benefits of taking this combination of medicines may outweigh any risks associated with therapeutic duplication. This information does not take the place of talking to your doctor. Always check with your healthcare provider to determine if any adjustments to your medications are needed.

Duplication

Cardiac stressing agents

Therapeutic duplication

The recommended maximum number of medicines in the 'cardiac stressing agents' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'cardiac stressing agents' category:

  • aspirin/dipyridamole
  • dipyridamole

Note: The benefits of taking this combination of medicines may outweigh any risks associated with therapeutic duplication. This information does not take the place of talking to your doctor. Always check with your healthcare provider to determine if any adjustments to your medications are needed.

Drug Interaction Classification

The classifications below are a guideline only. The relevance of a particular drug interaction to a specific patient is difficult to determine using this tool alone given the large number of variables that may apply.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide